Neoadjuvant Chemotherapy: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Neoadjuvant Chemotherapy

• Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
  NCT06735118 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
  NCT06107920 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 28 locations
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
  NCT06977893 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 13 locations
• Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
  NCT06914440 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
  NCT07383818 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 5 locations
• Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
  NCT07081360 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Neoadjuvant Chemotherapy?

6 recruiting trials across 14 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.